-
Chronic Kidney Disease and Osteoporosis
The prevalence of both osteoporosis and chronic kidney disease increase with aging. The frequency with which they both occur in the same individual is high. How to differentiate osteoporosis from chronic kidney disease-mineral and how to treat each bone disorder is the subject of much debate. Dr. Miller, an international […]
-
Medical Considerations in Athletes With Stress Fractures
Dr. Elliott Schwartz reviews the causes, epidemiology, evaluation, diagnosis and approach to individuals with stress fractures. He discusses his work with elite athletes and offers his thoughts and information about new approaches to treatment of this condition. Recorded at Northern California Institute for Bone Health, Osteoporosis Update 2015, on June […]
-
Biology of Fracture Nonunions 2015
Dr. Elliott Schwartz reviews the definitions and causes of fracture nonunions, the possible underlying genetic issues, his experience treating such problems and his thoughts and information about new approaches to this vexing problem. Recorded at Northern California Institute for Bone Health, Osteoporosis Update 2015, on June 19, 2015, in Oakland, […]
-
Major Advance In Bone Densitometry
On November 11, 2013, we installed a new recently FDA approved software to our bone density machines which produces a report known as Trabecular Bone Score (TBS). TBS creates a textured image from the spine DXA image. It involves NO added radiation for you but analyzes the spine DXA image […]
-
Stress Fractures About the Tibia, Foot, and Ankle
From the Summit Medical Group, Morristown, NJ (Dr. Shindle), the Department of Radiology and Imaging (Dr. Endo), the Department of Orthopedic Surgery (Dr. Warren and Dr. Ellis), and the Orthopedic Trauma Service (Dr. Lane and Dr. Helfet), Hospital for Special Surgery, New York, NY, and the Northern California Institute for […]
-
Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.
Miller PD, Schwartz EN, Chen P, Misurski DA, Krege JH. INTRODUCTION: The prevalence of both osteoporosis and renal impairment increases with age. METHODS: Using data from the Fracture Prevention Trial, the safety and efficacy of teriparatide [rhPTH(1-34)] in postmenopausal women with osteoporosis and renal impairment were explored.
